Rheumatoid Arthritis News and Research

Latest Rheumatoid Arthritis News and Research

Pneumococcal vaccinations help protect patients with rheumatoid arthritis against serious pneumococcal infections of the lungs, brain, blood, and ears

Rheumatoid arthritis patients have an approximately two-fold increased morbidity and mortality in infections compared to a population without the disease.

18 Oct 2004

Signaling pathway could be a valuable target for future drug therapies against systemic lupus erythematosus

Medical investigators at the Hospital for Special Surgery have identified an important new signaling pathway they believe could be a valuable target for scientists to aim at with future drug therapies that might one day reverse diseases such as systemic lupus erythematosus, according to a recent article published in “Nature Immunology.”

11 Oct 2004

Atheromatosis, which lies behind heart attacks, stroke, and other cardiovascular problems, has a major impact on public health

These two diseases are completely different from each other, but they do have one common denominator: inflammation. Researchers at Lund University in Sweden can now show that it might also be possible to treat them with the same drug.

10 Oct 2004

Shortage of pediatric rheumatologists often leads to improper diagnosis and treatment

More than 150,000 children in the United States are affected by rheumatic diseases such as juvenile rheumatoid arthritis, lupus, dermatomyositis, scleroderma, and systemic vasculitis.

10 Oct 2004

Rheumatoid arthritis results from a combination of genetic susceptibility and environmental triggers

Rheumatoid arthritis (RA), like many chronic diseases of the immune system, likely results from a combination of genetic susceptibility and environmental triggers.

7 Oct 2004

Immediate voluntary world-wide withdrawal of Vioxx (rofecoxib)

Pharmaceutical company, Merck Sharp & Dohme has announced an immediate voluntary world-wide withdrawal of the drug, Vioxx (rofecoxib), commonly used for patients with rheumatoid or osteoarthritis.

4 Oct 2004

MHRA advice following withdrawal of Vioxx (rofecoxib)

The Medicines and Healthcare products Regulatory Agency (MHRA) has issued advice following the withdrawal of a widely-used pain-killer and anti-inflammatory drug Vioxx (rofecoxib).

4 Oct 2004

Study to test the effectiveness of anti-depressants in treating symptoms of Parkinson’s disease

While Parkinson’s disease typically brings to mind symptoms such as tremors and slow movement, researchers have found that nearly half of all Parkinson’s patients also suffer from depression. While it might seem natural that someone who has a disease such as Parkinson’s might become depressed, it’s not so simple, says neurologist Irene Richard, M.D., who leads the study.

27 Sep 2004

Study on the long-term health effects associated with silicone breast implants

It is estimated that between 1.5 million and 2 million women in this country have had breast implants since they first appeared on the market in 1962.

23 Sep 2004

So far only 4,000 of 50,000 slots have been filled in new demonstration prescription drug assistance program

The Chairman of the U.S. Senate Special Committee on Aging is encouraging those on Medicare who have cancer and other serious diseases to consider signing up for a new demonstration prescription drug assistance program.

18 Sep 2004

Study looks at the patient-practitioner relationship in complementary and alternative therapies

Why do patients opt for complementary and alternative therapies when they are ill? Is the relationship and communication between a patient and a practitioner as important in the treatment as the complementary treatments prescribed?

6 Sep 2004

Children who take steroid drugs for nephrotic syndrome do not suffer bone loss

Childhood nephrotic syndrome, which affects 3 out of 100,000 children, is the most common chronic kidney disease in children. Although it does not impair kidney function, it weakens the body's ability to remove water and salt from the blood, and causes swelling in the belly, legs, and around the eyes.

25 Aug 2004

Novel disease mechanism underlying rheumatoid arthritis

Investigators at the Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center (LA BioMed) have identified a novel disease mechanism underlying rheumatoid arthritis that may open the door to new therapies for this and other debilitating autoimmune disorders.

23 Aug 2004

Researchers find important gene for lupus

Researchers at the University of Minnesota have identified, for the first time, a gene variation associated with systemic lupus erythematosus (SLE), a potentially fatal disease which causes the body's defence system to attack itself.

18 Aug 2004

Two more drugs added to Medicare demonstration program

The Centers for Medicare & Medicaid Services has announced it is adding two more drugs to the list of drugs covered under a Medicare demonstration program providing substantial savings to beneficiaries with serious diseases, including cancer, multiple sclerosis, and rheumatoid arthritis.

17 Aug 2004

Never mind the gills here's the oyster gonads

The researchers studied 8 Sydney rock oysters, concentrating on the levels of omega-3 fatty acids in the gills, muscles and gonads.

11 Aug 2004

Bionomics BNO69 angiogenesis gene discovery published

Bionomics has announced that research conducted by Bionomics and its collaborators at the Hanson Centre of the Institute of Medical and Veterinary Science ("IMVS") in Adelaide, Australia, relating to Bionomics' proprietary angiogenesis drug target BNO69, has been published in the high ranking scientific journal Proceedings of the National Academy of Sciences USA (PNAS).

10 Aug 2004

Study to determine how people with rheumatoid arthritis evaluate improvements in disease symptoms

The study will examine how much of an improvement in pain, stiffness, function and other symptoms is needed before patients consider the change important.

7 Aug 2004

Rheumatoid arthritis and early indicators of disease

A chronic autoimmune disease marked by severe inflammation and joint, rheumatoid arthritis (RA) is a major cause of pain and disability.

5 Aug 2004

New clinical study to determine how people with rheumatoid arthritis evaluate improvements in disease symptoms

A new clinical study to determine how people with rheumatoid arthritis (RA) evaluate improvements in disease symptoms will be carried out by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), part of the Department of Health and Human Services' National Institutes of Health.

5 Aug 2004

Rheumatoid Arthritis News and Research

Latest Rheumatoid Arthritis News and Research

Pneumococcal vaccinations help protect patients with rheumatoid arthritis against serious pneumococcal infections of the lungs, brain, blood, and ears

Signaling pathway could be a valuable target for future drug therapies against systemic lupus erythematosus

Atheromatosis, which lies behind heart attacks, stroke, and other cardiovascular problems, has a major impact on public health

Shortage of pediatric rheumatologists often leads to improper diagnosis and treatment

Rheumatoid arthritis results from a combination of genetic susceptibility and environmental triggers

Immediate voluntary world-wide withdrawal of Vioxx (rofecoxib)

MHRA advice following withdrawal of Vioxx (rofecoxib)

Study to test the effectiveness of anti-depressants in treating symptoms of Parkinson’s disease

Study on the long-term health effects associated with silicone breast implants

So far only 4,000 of 50,000 slots have been filled in new demonstration prescription drug assistance program

Study looks at the patient-practitioner relationship in complementary and alternative therapies

Children who take steroid drugs for nephrotic syndrome do not suffer bone loss

Novel disease mechanism underlying rheumatoid arthritis

Researchers find important gene for lupus

Two more drugs added to Medicare demonstration program

Never mind the gills here's the oyster gonads

Bionomics BNO69 angiogenesis gene discovery published

Study to determine how people with rheumatoid arthritis evaluate improvements in disease symptoms

Rheumatoid arthritis and early indicators of disease

New clinical study to determine how people with rheumatoid arthritis evaluate improvements in disease symptoms

Innovation in neuroscience drug discovery - eBook eBook

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Rheumatoid Arthritis News and Research

Latest Rheumatoid Arthritis News and Research

Innovation in neuroscience drug discovery - eBook eBook

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Newsletters you may be interested in